Navigation Links
Hookworms in MS trial
Date:3/3/2009

Scientists from The University of Nottingham will study the potential health benefits of parasitic worms as part of a study investigating treatments for people with the autoimmune condition multiple sclerosis (MS).

It is thought that hookworms may play a role in damping down the immune system, which is overactive in people with MS, the most disabling neurological condition in young adults.

The 400,000, three-year project funded by the MS Society, aims to determine whether infection with a small and harmless number of the worms can lead to an improvement on the severity of MS over a 12 month period.

If the trial is successful, the worms have the potential to provide a simple, cheap, natural and controllable treatment for MS.

The WIRMS (Worms for Immune Regulation in MS) study is led by Professor Cris Constantinescu and Professor David Pritchard and is a randomised, placebo controlled, phase 2 study in people with relapsing remitting MS and will be carried out at multiple centres up and down the country.

The 25 worms are microscopic and are introduced painlessly through a patch in the arm. They are then flushed out after nine months.

Professor Constantinescu, said: "People are really interested in this form of potential therapy because it's a natural treatment. It's been tested for safety and we now need to study the potential benefits and any side effects."

Jayne Spink, Director of Research at the MS Society said: "It sounds like science fiction, but it has been shown in a previous small study that people with MS who also had gut parasite infections had fewer relapses.

"Over time, parasitic worms have evolved to be able to survive an immune system attack and have been linked to a reduction in the severity of the symptoms of MS, which can be debilitating.

"If the theories can be shown to be accurate, using hookworms as a future treatment option may prove to be science fact."

'/>"/>
Contact: Professor Cris Constantinescu
cris.constantinescu@nottingham.ac.uk
44-011-584-66597
University of Nottingham
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Marinus Pharmaceuticals, Inc. Announces Positive Results of its Phase 2 Clinical Trial of Ganaxolone as Adjunctive Therapy in Adults With Partial Onset Seizures
2. CANTAM first African Network of Excellence for clinical trials
3. Stemedica Advances its Certification to Become a Licensed Manufacturer of Adult Stem Cells for U.S. Based Clinical Trials
4. Medivation to Host Conference Call and Slide Presentation at 4:30 p.m. EST Wednesday, February 25, to Discuss New MDV3100 Efficacy and Safety Data From Trial in Castration-Resistant Prostate Cancer Patients
5. As a Result of the Jupiter Trial, 65 Percent of Surveyed MCO Pharmacy Directors Will Reimburse Crestor for Patients with Elevated hsCRP
6. Laser Therapy Disappoints in Stroke Trial
7. Landmark Trial Provides Vital Information for Cardiac Disease Treatment
8. Many Clinical Trials Moving Overseas
9. Arena Pharmaceuticals Announces Initiation by Merck of Phase 2 Clinical Trial of Niacin Receptor Agonist
10. Bioniche Phase II Bladder Cancer Trial Results Published in The Journal of Urology
11. Bradmer provides clinical trial update and announces evaluation of strategic alternatives

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...why this is so, however , , MONDAY, No... with very dense breasts have a higher risk of can... shows. , Breast density has already been linke...er, and experts have suspected that very dense bre... of cancer recurrence at the site of the original ...
(Date:11/9/2009)...wire-USNewswire/ -- Speaker Nancy Pelosi released...e Affordable Health Care for America Act (H.R....duce Medicare Part D costs for people living with ...y a vote of 220 to 215: ,, "Effective drug tre...ife for thousands of Americans living with HIV/AID...
(Date:11/9/2009)...PRNewswire/ -- Abt Associates continues to broad...ergency management consulting and support services...the work of the Federal Emergency Management Agenc...onal Commission on Children and Disasters and the ...ATA). The value of the combined contracts is appr...
(Date:11/9/2009)...mental Procedure for Preteen Son - ,, PHILADE...ts of children with cancer, the hopeful news is th... for decades. Among the bad news -- treatments tha... Boys diagnosed with cancer who have reached puber... fertility: before undergoing cancer treatment, th...
(Date:11/9/2009)...wire-USNewswire/ -- The American Academy of Physic...00 clinically practicing physician assistants (PAs...S. House of Representatives for passing Saturday i...ble Health Care for America Act. ,, "We are esp...ately lower the cost of health care and greatly ex...
Breaking Medicine News(10 mins):Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3Health News:Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS 2Health News:Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 4Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2
...hildren that jumping for joy can hurt them, accord...ship Children's Hospital, Auckland, have called fo...rising number of children being injured while jump...ncrease in pre-Christmas trampoline sales, compare...
...bviously a difficult question to answer. //There i...ving stem cell research that this is a fast growin... medicine. Ideally a properly funded nation... to us because that is not an option for them: the...
... dietary regime which will include lots of green v...amount of calcium. This type of food guide is the ...od Guide has addressed this guide to all the Canad...rescribed by the Food Guide may affect the sale of...
...ng blood loss in patients undergoing cardiac surge...during five years following// the surgery, accordi...ed for use in high-risk patients needing coronary ...ave received aprotinin since 1985, principally dur...
...ive compounds that stimulate white blood cell prod...herapy are at an increased// risk of developing a ...stic syndrome, according to a new study in the Feb...be taken into consideration when making treatment ...
...es Network (SIGN) has published a set of guideline...00 cardiovascular complaints// like heart attacks ... aims to provide preventive treatment to about 500...ms to provide lifestyle advice. As per the g...
Other Medicine News:Health News:Drug Used in Coronary Artery Bypass Surgery may Increase Risk of Death 2Health News:Growth Factors Given With Chemotherapy may Increase Risk of Blood Diseases 2Health News:Growth Factors Given With Chemotherapy may Increase Risk of Blood Diseases 3Health News:A New Plan to Restrict Cardiovascular Diseases in Scotland 2
(Date:11/9/2009)..., POTOMAC FALLS, Va., Nov. 9 Tess...croarray-based applications, announces the launch ...sting of the mutations that underlie human heredit...tise in microarray-based resequencing with novel n...ysis software enables screening for all targeted m...
(Date:11/9/2009)..., PALO ALTO, Calif., Nov. 9 Women... it has changed its name to Viveve as it prepares ...in select U.S. markets. ,, "Viveve is a name th...focus on women,s sexual health," said Kerry Pope, ...ists for the sole purpose of helping women restore...
(Date:11/9/2009)..., VIRGINIA BEACH, Va., Nov. 9 Lif...ny, announces the launch of Vertigraft Cervical Bi..., Preservon® is a new, proprietary glycero...t bio-implants to be stored in a fully hydrated st...ed to freeze or freeze-dry bio-implants, doing awa...
Breaking Medicine Technology:TessArae Delivers Lower Cost Option to Genetic Testing Market 2Women's Sexual Health Company Changes Name in Preparation for Market Entry 2LifeNet Health Announces First Bio-Implant with New Preservation Technology 2CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 1CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 2CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 3Astellas Named Elite Winner for Employee Engagement and Commitment in Chicagos 101 Best and Brightest Companies to Work For Competition 54247 1Astellas Named Elite Winner for Employee Engagement and Commitment in Chicagos 101 Best and Brightest Companies to Work For Competition 54247 2ParagonRx Sponsors Webinar on Demand By DSEC on Role of Drug Safety Officers 13507 1
L-Hook Electrode
...uments incorporate a layered design unique in the ...ed to prevent stray electrosurgical burns along th...lure or capacitive coupling; a well-documented pat... all AEM Instruments provides a neutral return pat...
...uments incorporate a layered design unique in the ...ed to prevent stray electrosurgical burns along th...lure or capacitive coupling; a well-documented pat... all AEM Instruments provides a neutral return pat...
...uments incorporate a layered design unique in the ...ed to prevent stray electrosurgical burns along th...lure or capacitive coupling; a well-documented pat... all AEM Instruments provides a neutral return pat...
Medicine Products: